VENMAX DRUGS AND PHARMACEUTICA Share Price

VENMAX DRUGS AND PHARMACEUTICA Share Price

BSE: 531015
|
Pharmaceuticals
|
S Cap
₹ 17.50
+₹0.58 (3.43%)
1D
Last updated 13 Aug, 2026, 14:29 IST

VENMAX DRUGS AND PHARMACEUTICA Share Price Today

As of 14 Aug 2026, VENMAX DRUGS AND PHARMACEUTICA share price is ₹17.50. The stock opened at ₹17.10, compared to its previous close of ₹16.92. During today's trading session, VENMAX DRUGS AND PHARMACEUTICA share price moved in the range of ₹17.10 to ₹17.70, with an average price of ₹17.40 for the day. Looking at its last 52-week, the stock has touched a low of ₹15.56 and a high of ₹36.96.

₹17.10
3.43% up today
₹17.70
1D LOW
1D HIGH

VENMAX DRUGS AND PHARMACEUTICA Returns Calculator

Circuit
L
H
₹13.54
₹20.30
52-week
L
H
₹15.56
₹36.96

About VENMAX DRUGS AND PHARMACEUTICA

VENMAX DRUGS AND PHARMACEUTICA Share Price
ISIN
INE154G01022
Sector Market Cap
₹ 25.35 Cr

Venmax Drugs and Pharmaceuticals Limited is an India-based company. The Company is engaged in the business of pharmaceutical products, drug intermediaries and active pharmaceutical ingredients (API’s). It is developing oncology products through research and development (R&D).

VENMAX DRUGS AND PHARMACEUTICA Financial Highlights

  • Revenue: VENMAX DRUGS AND PHARMACEUTICA reported revenue of ₹8.18 crore in FY26 vs ₹1.86 crore in FY25. It showed an increase of 339.78% on a yearly basis.
  • Operating Profit: VENMAX DRUGS AND PHARMACEUTICA reported an operating profit of ₹0.28 crore in FY26 vs ₹0.01 crore in FY25. It showed an increase of 2,900.00% on a year-on-year basis.
  • Net Profit: VENMAX DRUGS AND PHARMACEUTICA reported a net profit of ₹0.25 crore in FY26 vs ₹0.01 crore in FY25. It showed an increase of 2,600.00% on a yearly basis.

VENMAX DRUGS AND PHARMACEUTICA Quarterly Result Highlights

  • VENMAX DRUGS AND PHARMACEUTICA reported revenue of ₹2.48 crore in Jun 2026, compared with ₹4.03 crore in Mar 2026, representing a decrease of 38.46% on a quarter-on-quarter (QoQ) basis.
  • VENMAX DRUGS AND PHARMACEUTICA reported an operating profit of ₹0.12 crore in Jun 2026, compared with ₹0.10 crore in Mar 2026, representing an increase of 20.00% on a quarter-on-quarter (QoQ) basis.
  • VENMAX DRUGS AND PHARMACEUTICA reported a profit of ₹0.12 crore in Jun 2026, compared with ₹0.11 crore in Mar 2026, reflecting an increase of 9.09% on a QoQ basis.
  • The earnings per share (EPS) of VENMAX DRUGS AND PHARMACEUTICA stood at ₹0.02 during Jun 2026.
Know more
Promoters
10.46%
FII
0.00%
Other DII
0.00%
Retail and other
89.54%
Mutual funds
0.00%
Foreign institutions - FII
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
25.35
P/E
89.05
P/B
1.18
ROE
1.87%
D/E
0.01
ROCE
2.03%
Div. Yield
0.00%
EPS(TTM)
0.21
Turnover
0.55
EV/EBITDA
79.47
Net Margin
0.00%
Op. Margin
0.00%
ROA
1.66%
Quick Ratio
0.00
Curr. Ratio
10.45
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Venmax Drugs has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Venmax Drugs appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,64,271.0038.325.5613.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,26,843.0077.5513.5315.32%0.0019.56%629.490.35%0.5598.19
Torrent Pharmaceuticals1,86,000.0086.2722.1225.49%1.6913.85%222.760.69%0.4958.70
Zydus Lifesciences1,20,099.0026.154.4318.59%0.3117.35%237.300.08%0.3335.38
Cipla1,18,027.0035.183.4311.27%0.0014.95%423.360.89%0.4543.52
Lupin1,03,549.0018.624.6123.76%0.0424.88%659.050.79%0.57129.18
Mankind Pharma1,00,137.0048.436.1411.74%0.3413.13%397.020.04%0.4449.37
Dr. Reddy's Laboratories1,00,073.0031.622.6411.07%0.1812.54%377.960.67%0.4138.68
Laurus Labs99,474.2091.2318.7716.77%0.4016.14%97.200.11%0.6713.72
Aurobindo Pharma96,700.6026.062.559.25%0.1911.76%391.140.24%0.3841.58

VENMAX DRUGS AND PHARMACEUTICA Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹0.81₹0.00₹0.00₹0.00
Other Income₹1.05₹0.20₹0.42₹1.98
Total Revenue₹1.86₹0.20₹0.42₹1.98
Total Expenses₹1.87₹0.11₹0.19₹0.14
Profit Before Tax-₹0.01₹0.09₹0.23₹1.85
Tax₹0.00₹0.02₹0.00₹0.00
Profit After Tax-₹0.01₹0.06₹0.23₹1.85
EPS - Basic-₹0.02₹0.12₹0.43₹3.52
EPS - Diluted-₹0.02₹0.12₹0.43₹3.52

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹0.01₹0.09₹0.23₹1.85
Income before WC changes₹0.01₹0.09₹0.23₹1.86
Change in Assets-₹2.63₹0.13-₹0.09₹0.01
Change in Liabilities₹0.33-₹0.19-₹0.14₹0.04
Change in WC-₹2.30-₹0.07-₹0.24₹0.05
Cash flow from Operations-₹2.29₹0.00₹0.00₹1.91
Cash flow from Investing₹0.00₹0.00₹0.00₹0.00
Cash flow from Financing₹4.77₹0.00₹0.00-₹1.98
Total Cash Flow₹2.48₹0.00₹0.00-₹0.07
Cash (Start of the year)₹0.00₹0.00₹0.00₹0.08
Cash (End of the year)₹2.48₹0.00₹0.00₹0.00

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹0.04₹0.07₹0.07₹0.08
Current Assets₹5.13₹0.02₹0.14₹0.13
Total Assets₹5.17₹0.08₹0.21₹0.21
Current Liabilities₹0.76₹0.73₹0.92₹1.15
Net Current Asset₹4.37-₹0.71-₹0.78-₹1.02
Non-Current Liabilities₹0.00₹0.00₹0.00₹0.00
Equity Capital₹4.41-₹0.65-₹0.71-₹0.94
Total Equity & Liabilities₹5.17₹0.08₹0.21₹0.21
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
17.5
7240
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 7240
Buy orders: 0%
Sell orders: 100%
Bearish
2
Neutral
6
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
48.75
Neutral
ATR (14)
2.07
Neutral
STOCH(9,6)
47.88
Neutral
STOCH RSI (14)
59.91
Neutral
ADX(9)
32.74
Bearish
UO(9)
41.72
Neutral
ROC(12)
-0.34
Bearish
WillR(14)
-59.92
Neutral
Period
Simple value
Exponential vaue
5D
17.52
17.42
10D
17.28
17.4
20D
17.18
17.51
50D
18.44
18.75
100D
21.62
20.61
Volume trend — traded volume by day
13 Aug0L
12 Aug0L
11 Aug0L
10 Aug0L
7 Aug0L
Average0L
Compare against other stocks
VENMAX DRUGS AND PHARMACEUTICA Share Price
VENMAX DRUGS AND PHARMACEUTICA
Pharmaceuticals
Add Stock
Add Another

VENMAX DRUGS AND PHARMACEUTICA Share Price FAQs